NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

病患登錄軟體的全球市場 (∼2025年): 糖尿病、罕見疾病、癌症、腎臟病

Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User-Forecast to 2025

出版商 MarketsandMarkets 商品編碼 956664
出版日期 內容資訊 英文 254 Pages
訂單完成後即時交付
價格
病患登錄軟體的全球市場 (∼2025年): 糖尿病、罕見疾病、癌症、腎臟病 Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User-Forecast to 2025
出版日期: 2020年08月27日內容資訊: 英文 254 Pages
簡介

全球病患登錄軟體的市場規模在預測期間內預計將以14.4%的年複合成長率發展,從2020年的12億美元,成長到2025年24億美元的規模。由紙本轉移到電腦帶來的優點促進該市場的成長。還有新型冠狀病毒感染疾病 (COVID-19)的全球性流行和患者數的增加,也帶動軟體需求增加 。再加上ACO (Accountable Care Organization) 數的增加,訂閱模式的高引進率,雲端基礎解決方案的崛起等要素也促進該市場成長。同時,有才能的人力資源不足,隱私及安全上的疑慮等的課題妨礙市場進一步成長。

本報告提供全球病患登錄軟體的市場調查,市場定義和概要,COVID-19以及其他的市場影響因素分析,市場規模的變化、預測,登記類型、軟體類型、部署模型、定價模式、資料庫模式、功能、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 市場課題

第6章 產業考察

  • COVID-19的影響
  • HCIT支出分析:各地區
  • HCIT的引進趨勢:美國

第7章 市場分析、預測:各登記類型

  • 疾病登記
    • 糖尿病
    • 心血管
    • 癌症
    • 罕見疾病
    • 氣喘
    • 慢性腎臟病
    • 整形外科
    • 其他
  • 保健服務登記
  • 產品登記
    • 醫療設備
    • 醫藥品

第8章 市場分析、預測:各軟體類型

  • 獨立式
  • 整合型

第9章 市場分析、預測:各定價模式

  • 訂閱模式
  • 所有權模式

第10章 市場分析、預測:各部署模型

  • 內部部署
  • 雲端

第11章 市場分析、預測:各資料庫類型

  • 商用資料庫
  • 公共資料庫

第12章 市場分析、預測:各功能

  • PHM (POPULATION HEALTH MANAGEMENT)
  • 患者治療管理
  • 醫學研究、臨床研究
  • 健康資訊交流
  • POC (照護現場)
  • 產品評估

第13章 市場分析、預測:各終端用戶

  • 政府機關、第三方管理者
  • 醫院、醫療者
  • 民間保險者
  • 製藥、生物科技、醫療設備企業
  • 研究中心

第14章 市場分析、預測:各地區、主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 南美
  • 中東、非洲

第15章 競爭情形

  • 概要
  • 競爭領導製圖
  • 產品矩陣:各企業
  • 市場佔有率分析
  • 競爭情形、趨勢

第16章 企業簡介

  • PHYTEL
  • IQVIA HOLDINGS
  • OPENTEXT CORPORATION
  • SYNEOS HEALTH
  • FIGMD
  • IMAGETREND
  • CECITY.COM
  • DACIMA SOFTWARE
  • GLOBAL VISION TECHNOLOGIES
  • IFA SYSTEMS AG
  • M2S
  • MCKESSON CORPORATION
  • OPTUM
  • EVADO CLINICAL
  • VELOS
  • ARBORMETRIX
  • LUMEDX
  • HEALTHDIARY
  • CEDARON
  • PHAMAX AG

第17章 附錄

目錄
Product Code: HIT 3094

Title:
Patient Registry Software Market
by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) - Forecast to 2025.

"Rising adoption of electronic health records and other e-health solutions are driving market growth"

The global patient registry software market is projected to reach USD 2.4 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. The shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software. Other considerations include the rising number of accountable care organizations, high adoption of the subscription model, and the emergence of cloud-based patient registry solutions. However, shortage of trained and skilled resources and privacy and security related concerns hampered market growth to an extent.

"Diseases Registries was the largest and fastest growing segment in the type of registry market in 2019"

These registries include information on patients diagnosed with a specific disease. The main inclusion criterion that disease or condition registries use is the state of a particular disease or condition. Factors such as the Increasing government initiatives to develop and maintain patient health records (to reduce healthcare costs) and the growing awareness about collecting and utilizing patient health information are driving the adoption of disease registries. The value of disease registries is increasingly being recognized as they provide historically comparable data and long-term evaluation, potentially serving as an addition to randomized clinical trials, and thus providing insights about real-site outcomes that limited controlled studies do not address. However, the development of disease registries might become costlier as the scope of the study increases.

"Commercial Databases is the largest type of database segment in the patient registry software market in 2019"

Based on the type of database, the patient registry software market is segmented into commercial databases and public databases. A growing number of pharmaceutical/drug manufacturing and medical device companies are opting for commercial databases owing to their use in a number of studies, including the identification of adverse effects of drugs/medical devices, post-marketing surveillance, and the study of population disease patterns. . Commercial registries are generally privately funded or industry-sponsored and aim to gather patient-related data for continual delivery of quality care.

"Government organizations & TPAs is the largest end user segment in the patient registry software market in 2019"

Based on the end user, the patient registry software market is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & TPAs. In 2019, the government organizations & TPAs segment accounted for the largest share of the global patient registry software market. The large share of this segment can be attributed to the emergence of the COVID-19 pandemic and the need for analyzing patient data for better population health management.

"North America will continue to dominate the patient registry software market in 2025"

The patient registry software market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share of 48.9% of the global patient registry software market. The large share of North America in the global market is attributed to the increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on PHM and HIE, increasing adoption of HCIT as a cost-containment measure, and the participation of non-profit and private organizations in improving patient care quality. Due to its growing geriatric population segment and environmental conditions have favored the spread of COVID-19 which has severely affected the region and ensured enormous growth in the demand for patient registry software. Players in this and adjacent, or even non-related, markets have focused on or collaborated for expanding the offerings of this market segment.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
  • By Designation - C-level: 25%, Director-level: 20%, and Others: 55%
  • By Region - North America: 40%, Europe: 25%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 5%

Research Coverage:

The report analyzes the patient registry software market and aims at estimating the market size and future growth potential of various market segments, based on type of registry, software, pricing model, deployment model, type of database, functionality, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the patient registry software market. The report analyzes this market by type of registry, software, pricing model, deployment model, type of database, functionality, end user, and region.
  • Market Development: Comprehensive information on the lucrative emerging markets, type of registry, software, pricing model, deployment model, type of database, functionality, end user, and region
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient registry software market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient registry software market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 PATIENT REGISTRY SOFTWARE MARKET
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
    • TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 7 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2020 VS. 2025 (USD MILLION)
    • FIGURE 11 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 13 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020 VS. 2025 (USD MILLION)
    • FIGURE 14 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE PATIENT REGISTRY SOFTWARE MARKET

4 PREMIUM INSIGHTS

  • 4.1 PATIENT REGISTRY SOFTWARE MARKET OVERVIEW
    • FIGURE 16 RISING ADOPTION OF ELECTRONIC HEALTH RECORDS AND OTHER E-HEALTH SOLUTIONS ARE DRIVING MARKET GROWTH
  • 4.2 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY AND COUNTRY (2019)
    • FIGURE 17 DISEASE REGISTRIES ACCOUNTED FOR THE LARGEST SHARE OF THE APAC PATIENT REGISTRY SOFTWARE MARKET IN 2019
  • 4.3 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • 4.4 REGIONAL MIX: PATIENT REGISTRY SOFTWARE MARKET (2020-2025)
    • FIGURE 19 NORTH AMERICA WILL CONTINUE TO DOMINATE THE PATIENT REGISTRY SOFTWARE MARKET IN 2025
  • 4.5 PATIENT REGISTRY SOFTWARE MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Implementation of government initiatives to build patient registries
      • 5.2.1.2 Rising pressure to improve the quality of care and reduce healthcare costs
      • 5.2.1.3 Rising adoption of EHRs and other eHealth solutions
      • 5.2.1.4 Growing patient volume due to the global outbreak of COVID-19
      • 5.2.1.5 Growing use of patient registry data for post-marketing surveillance
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Privacy- and data security-related concerns
      • 5.2.2.2 Shortage of trained and skilled resources
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Rising number of accountable care organizations
      • 5.2.3.2 Emergence of cloud-based patient registry solutions
      • 5.2.3.3 High adoption rate of the subscription model
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Lack of interoperability and integration
      • 5.2.4.2 Reluctance to adopt advanced solutions
      • 5.2.4.3 Lack of awareness

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 IMPACT OF COVID-19 ON THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 2 COVID-19 PATIENT REGISTRIES
    • 6.2.1 SHIFTING FOCUS TOWARD PATIENT-POWERED RESEARCH NETWORKS
  • 6.3 HCIT EXPENDITURE ANALYSIS
    • 6.3.1 NORTH AMERICA
    • TABLE 3 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
    • 6.3.2 EUROPE
    • 6.3.3 ASIA PACIFIC
  • 6.4 HCIT ADOPTION TRENDS IN THE US
    • FIGURE 22 US: OFFICE-BASED PHYSICIAN EHR ADOPTION (2004-2017)
    • FIGURE 23 US: HOSPITAL EHR ADOPTION (2007-2018)

7 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY

  • 7.1 INTRODUCTION
    • TABLE 4 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
  • 7.2 DISEASE REGISTRIES
    • TABLE 5 DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 6 DISEASE REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.1 DIABETES REGISTRIES
      • 7.2.1.1 Growing obese and geriatric populations to drive market growth
    • TABLE 7 DIABETES REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 8 DIABETES REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.2 CARDIOVASCULAR REGISTRIES
      • 7.2.2.1 Rising prevalence of heart diseases and strokes worldwide to drive market growth
    • TABLE 9 CARDIOVASCULAR REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 10 CARDIOVASCULAR REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.3 CANCER REGISTRIES
      • 7.2.3.1 Increasing need to manage the growing number of cancer patients across the globe to propel market growth
    • TABLE 11 CANCER REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 12 CANCER REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.4 RARE DISEASE REGISTRIES
      • 7.2.4.1 Increasing funding for research on rare diseases and their treatments to boost market growth
    • TABLE 13 RARE DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 14 RARE DISEASE REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.5 ASTHMA REGISTRIES
      • 7.2.5.1 Increasing prevalence of asthma is one of the major drivers for market growth
    • TABLE 15 ASTHMA REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 16 ASTHMA REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.6 CHRONIC KIDNEY DISEASE REGISTRIES
      • 7.2.6.1 Rising prevalence of chronic kidney diseases to drive market growth
    • TABLE 17 CHRONIC KIDNEY DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 18 CHRONIC KIDNEY DISEASE REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.7 ORTHOPEDIC REGISTRIES
      • 7.2.7.1 Growing number of patients suffering from orthopedic diseases to drive market growth
    • TABLE 19 ORTHOPEDIC REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 20 ORTHOPEDIC REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.8 OTHER DISEASE REGISTRIES
    • TABLE 21 OTHER DISEASE REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.3 HEALTH SERVICE REGISTRIES
    • 7.3.1 THESE REGISTRIES CAPTURE SERVICE-GENERATED DATA DERIVED FROM HEALTH FACILITIES
    • TABLE 22 HEALTH SERVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 23 HEALTH SERVICE REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.4 PRODUCT REGISTRIES
    • TABLE 24 PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 25 PRODUCT REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.4.1 MEDICAL DEVICE REGISTRIES
      • 7.4.1.1 Strong government support and initiatives to drive the demand for medical device registries
    • TABLE 26 MEDICAL DEVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 27 MEDICAL DEVICE REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.4.2 DRUG REGISTRIES
      • 7.4.2.1 Increasing post-marketing surveillance of drugs to drive market growth
    • TABLE 28 DRUGS REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
    • TABLE 29 DRUG REGISTRIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE

  • 8.1 INTRODUCTION
    • TABLE 30 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
  • 8.2 STANDALONE SOFTWARE
    • 8.2.1 STANDALONE SOFTWARE WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD
    • TABLE 31 STANDALONE SOFTWARE OFFERED BY KEY MARKET PLAYERS
    • TABLE 32 STANDALONE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.3 INTEGRATED SOFTWARE
    • 8.3.1 INTEGRATED SOFTWARE SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
    • TABLE 33 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS
    • TABLE 34 INTEGRATED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY 2018-2025 (USD MILLION)

9 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL

  • 9.1 INTRODUCTION
    • TABLE 35 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
  • 9.2 SUBSCRIPTION MODEL
    • 9.2.1 LOW COST OF SUBSCRIPTION MODELS TO SUPPORT THE GROWTH OF THIS SEGMENT
    • TABLE 36 SUBSCRIPTION-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.3 OWNERSHIP MODEL
    • 9.3.1 RISING ADOPTION OF THE INTEGRATED SOFTWARE MODEL WILL SUPPORT THE GROWTH OF THIS SEGMENT
    • TABLE 37 OWNERSHIP-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

10 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL

  • 10.1 INTRODUCTION
    • TABLE 38 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
  • 10.2 ON-PREMISE MODEL
    • 10.2.1 ON-PREMISE SOLUTIONS REDUCE THE RISK OF DATA BREACHES AND OTHER SECURITY ISSUES
    • TABLE 39 ON-PREMISE PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
    • TABLE 40 ON-PREMISE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 10.3 CLOUD-BASED MODEL
    • 10.3.1 CLOUD-BASED SOLUTIONS HELP HEALTHCARE ORGANIZATIONS SHARE AND INTEGRATE INFORMATION FROM DISPARATE LOCATIONS IN REAL-TIME
    • TABLE 41 CLOUD-BASED PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
    • TABLE 42 CLOUD-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

11 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE

  • 11.1 INTRODUCTION
    • TABLE 43 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
  • 11.2 COMMERCIAL DATABASES
    • 11.2.1 COMMERCIAL REGISTRIES ARE GENERALLY PRIVATELY FUNDED OR INDUSTRY-SPONSORED
    • TABLE 44 PATIENT REGISTRY SOFTWARE FOR COMMERCIAL DATABASES OFFERED BY KEY MARKET PLAYERS
    • TABLE 45 PATIENT REGISTRY SOFTWARE MARKET FOR COMMERCIAL DATABASES, BY COUNTRY, 2018-2025 (USD MILLION)
  • 11.3 PUBLIC DATABASES
    • 11.3.1 PUBLIC REGISTRIES ARE FUNDED BY FEDERAL, STATE, OR LOCAL GOVERNMENT AGENCIES
    • TABLE 46 PATIENT REGISTRY SOFTWARE FOR PUBLIC DATABASES OFFERED BY KEY MARKET PLAYERS
    • TABLE 47 PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC DATABASES, BY COUNTRY, 2018-2025 (USD MILLION)

12 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY

  • 12.1 INTRODUCTION
    • TABLE 48 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
  • 12.2 POPULATION HEALTH MANAGEMENT
    • 12.2.1 INCREASING DEMAND FOR QUALITY CARE IS DRIVING THE ADOPTION OF PHM SOLUTIONS
    • TABLE 49 PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • 12.3 PATIENT CARE MANAGEMENT
    • 12.3.1 GOVERNMENT INITIATIVES AND REGULATIONS PROMOTING PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH
    • TABLE 50 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2018-2025 (USD MILLION)
  • 12.4 MEDICAL RESEARCH & CLINICAL STUDIES
    • 12.4.1 CONTINUOUS RESEARCH FOR THE COVID-19 VACCINE IS SUPPORTING THE GROWTH OF THIS SEGMENT.
    • TABLE 51 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • 12.5 HEALTH INFORMATION EXCHANGE
    • 12.5.1 INCREASING NEED FOR SHARING OF VITAL PATIENT INFORMATION WITH CARE PROVIDERS SUPPORTS ADOPTION OF SOLUTIONS
    • TABLE 52 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2018-2025 (USD MILLION)
  • 12.6 POINT OF CARE
    • 12.6.1 URGENT NEED FOR STREAMLINED PATIENT CARE PROCESS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 53 PATIENT REGISTRY SOFTWARE MARKET FOR POINT OF CARE, BY COUNTRY, 2018-2025 (USD MILLION)
  • 12.7 PRODUCT OUTCOME EVALUATION
    • 12.7.1 INCREASING POST-MARKETING SURVEILLANCE IN BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES IS LIKELY TO PROPEL MARKET GROWTH
    • TABLE 54 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT OUTCOME EVALUATION, BY COUNTRY, 2018-2025 (USD MILLION)

13 PATIENT REGISTRY SOFTWARE MARKET, BY END USER

  • 13.1 INTRODUCTION
    • TABLE 55 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 13.2 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS
    • 13.2.1 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS HOLD LARGEST SHARE IN THE END-USER MARKET
    • TABLE 56 PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT ORGANIZATIONS & TPAS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 13.3 HOSPITALS & MEDICAL PRACTICES
    • 13.3.1 DEMAND FOR REGISTRY SOFTWARE SUPPORTED BY A GROWING FOCUS ON PATIENT SAFETY AND IMPROVING PATIENT OUTCOMES
    • TABLE 57 PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS & MEDICAL PRACTICES, BY REGION, 2018-2025 (USD MILLION)
  • 13.4 PRIVATE PAYERS
    • 13.4.1 NEED TO CURB RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH
    • TABLE 58 PATIENT REGISTRY SOFTWARE MARKET FOR PRIVATE PAYERS, BY REGION, 2018-2025 (USD MILLION)
  • 13.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES
    • 13.5.1 EVOLVING REGULATORY GUIDELINES ON PATIENT SAFETY BY REGULATORY BODIES TO PROPEL THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 59 PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 13.6 RESEARCH CENTERS
    • 13.6.1 INCREASE IN CLINICAL TRIALS & RESEARCH ON DISEASE TREATMENT SUPPORTS THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 60 PATIENT REGISTRY SOFTWARE MARKET FOR RESEARCH CENTERS, BY REGION, 2018-2025 (USD MILLION)

14 PATIENT REGISTRY SOFTWARE MARKET, BY REGION

  • 14.1 INTRODUCTION
    • FIGURE 24 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 61 PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 14.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
    • TABLE 62 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 63 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 64 NORTH AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 65 NORTH AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 66 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 67 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 68 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 69 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 70 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 71 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.2.1 US
      • 14.2.1.1 The US is the largest market for patient registry software
    • TABLE 72 US: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 73 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 74 US: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 75 US: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 76 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 77 US: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 78 US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 79 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 80 US: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 81 US: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.2.2 CANADA
      • 14.2.2.1 Launch of new government initiatives is expected to drive the adoption of patient registry software across the country
    • TABLE 82 CANADA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 83 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 84 CANADA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 85 CANADA: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 86 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 87 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 88 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 89 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 90 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 91 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 14.3 EUROPE
    • TABLE 92 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
    • TABLE 93 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 94 EUROPE: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 95 EUROPE: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 96 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 97 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 98 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 99 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 100 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 101 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 157
    • 14.3.1 UK
      • 14.3.1.1 Government initiatives to support market growth
    • TABLE 102 UK: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 103 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 104 UK: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 105 UK: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 106 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 107 UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 108 UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 109 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 110 UK: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 111 UK: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.3.2 GERMANY
      • 14.3.2.1 High healthcare spending to support the adoption of patient registry software solutions in Germany
    • TABLE 112 GERMANY: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 113 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 114 GERMANY: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 115 GERMANY: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 116 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 117 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 118 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 119 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 120 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 121 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.3.3 FRANCE
      • 14.3.3.1 Large number of COVID-19 cases to support market growth
    • TABLE 122 FRANCE: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 123 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 124 FRANCE: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 125 FRANCE: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 126 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 127 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 128 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 129 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 130 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 131 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.3.4 ITALY
      • 14.3.4.1 Rising prevalence of chronic diseases to increase the demand for patient registry software
    • TABLE 132 ITALY: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 133 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 134 ITALY: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 135 ITALY: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 136 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 137 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 138 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 139 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 140 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 141 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.3.5 SPAIN
      • 14.3.5.1 Government initiatives to improve the adoption of patient registry software and eHealth solutions are major market drivers
    • TABLE 142 SPAIN: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 143 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 144 SPAIN: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 145 SPAIN: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 146 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 147 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 148 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 149 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 150 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 151 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.3.6 REST OF EUROPE
    • TABLE 152 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 153 ROE: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 154 ROE: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 155 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 156 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 157 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 158 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 159 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 160 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 14.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
    • TABLE 161 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 162 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 165 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 166 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 167 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 169 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 170 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.4.1 JAPAN
      • 14.4.1.1 Japan has one of the highest adoption rates of EMR and patient registry software solutions in the Asia Pacific
    • TABLE 171 JAPAN: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 172 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 173 JAPAN: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 174 JAPAN: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 175 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 176 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 177 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 178 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 179 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 180 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.4.2 CHINA
      • 14.4.2.1 Absence of a patient-centered model may challenge the adoption of patient registry software and related markets in the country
    • TABLE 181 CHINA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 182 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 183 CHINA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 184 CHINA: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 185 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 186 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 187 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 188 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 189 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 190 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.4.3 INDIA
      • 14.4.3.1 India is currently one of the lucrative emerging regions in the field of eHealth
    • TABLE 191 INDIA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
    • TABLE 192 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 193 INDIA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 194 INDIA: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 195 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 196 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 197 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 198 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 199 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 200 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 14.4.4 REST OF ASIA PACIFIC
    • TABLE 201 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 202 ROAPAC: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 203 ROAPAC: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 204 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 205 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 206 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 207 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 208 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 209 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 14.5 LATIN AMERICA
    • 14.5.1 LATIN AMERICA HAS A LOWER ADOPTION RATE OF EHR SOLUTIONS
    • TABLE 210 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 211 LATIN AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 212 LATIN AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 213 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 214 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 215 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 216 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 217 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 218 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 14.6 MIDDLE EAST & AFRICA
    • 14.6.1 IMPLEMENTATION OF PATIENT REGISTRY SOFTWARE ACROSS PRIVATE SECTORS HAS BEEN EXTREMELY SLOW PACED
    • TABLE 219 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018-2025 (USD MILLION)
    • TABLE 220 MIDDLE EAST & AFRICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 221 MIDDLE EAST & AFRICA: DISEASE REGISTRIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 222 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018-2025 (USD MILLION)
    • TABLE 223 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018-2025 (USD MILLION)
    • TABLE 224 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018-2025 (USD MILLION)
    • TABLE 225 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018-2025 (USD MILLION)
    • TABLE 226 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
    • TABLE 227 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
    • FIGURE 27 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, & COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES
  • 15.2 COMPETITIVE LEADERSHIP MAPPING
    • 15.2.1 STARS
    • 15.2.2 EMERGING LEADERS
    • 15.2.3 PERVASIVE COMPANIES
    • 15.2.4 EMERGING COMPANIES
    • FIGURE 28 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • 15.3 PRODUCT MATRIX, BY COMPANY
    • FIGURE 29 R&D EXPENDITURE BY KEY PLAYERS IN THE PATIENT REGISTRY SOFTWARE MARKET, 2018 VS. 2019 (USD MILLION)
  • 15.4 MARKET SHARE ANALYSIS
    • FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET RANKING ANALYSIS, BY PLAYER, 2019
  • 15.5 COMPETITIVE SITUATIONS & TRENDS
    • 15.5.1 PRODUCT LAUNCHES
    • TABLE 228 KEY PRODUCT LAUNCHES
    • 15.5.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • TABLE 229 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 15.5.3 ACQUISITIONS
    • TABLE 230 KEY ACQUISITIONS

16 COMPANY PROFILES

(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)**

  • 16.1 PHYTEL
    • FIGURE 31 IBM CORPORATION: COMPANY SNAPSHOT
  • 16.2 IQVIA HOLDINGS
    • FIGURE 32 IQVIA HOLDINGS: COMPANY SNAPSHOT (2019)
  • 16.3 OPENTEXT CORPORATION
    • FIGURE 33 OPENTEXT CORPORATION: COMPANY SNAPSHOT (2019)
  • 16.4 SYNEOS HEALTH
    • FIGURE 34 SYNEOS HEALTH: COMPANY SNAPSHOT (2019)
  • 16.5 FIGMD
  • 16.6 IMAGETREND
  • 16.7 CECITY.COM
    • FIGURE 35 PREMIER: COMPANY SNAPSHOT
  • 16.8 DACIMA SOFTWARE
  • 16.9 GLOBAL VISION TECHNOLOGIES
  • 16.10 IFA SYSTEMS AG
    • FIGURE 36 IFA SYSTEMS AG: COMPANY SNAPSHOT (2018)
  • 16.11 M2S
  • 16.12 MCKESSON CORPORATION
    • FIGURE 37 MCKESSON CORPORATION: COMPANY SNAPSHOT (2020)
  • 16.13 OPTUM
    • FIGURE 38 OPTUM: COMPANY SNAPSHOT (2019)
  • 16.14 EVADO CLINICAL
  • 16.15 VELOS
  • 16.16 ARBORMETRIX
  • 16.17 LUMEDX
  • 16.18 HEALTHDIARY
  • 16.19 CEDARON
  • 16.20 PHAMAX AG

*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

17 APPENDIX

  • 17.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 17.2 DISCUSSION GUIDE
  • 17.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.4 AVAILABLE CUSTOMIZATIONS
  • 17.5 RELATED REPORTS
  • 17.6 AUTHOR DETAILS 263